CENTER VALLEY, Pa., Dec. 14, 2011 /PRNewswire-iReach/ -- Olympus America Inc. today expanded its medical portfolio by introducing a collection of EZ Shot 2 single-use aspiration needles for Endoscopic Ultrasound (EUS) procedures.The four unique needles offer excellent puncture capability along with an adjustable sheath designed to help physicians more accurately approach the targeted site. Available in a complete selection of sizes and styles, the surface of the EZ Shot 2 needle is designed with unique echogenic dimples to ensure it is clearly visible while performing endoscopic ultrasound.
"As a leading innovator of EUS technology, Olympus is committed to helping our customers help their patients, using state of the art endoscopic ultrasound imaging and diagnostic tools," commented Patrick MacCarthy, Vice President of Marketing for the Endoscopy Division of Olympus America. "We are very excited about our new, complete lineup of EZ Shot 2 needles, which represent the latest in EUS needle technology. Together with Olympus' market-leading EUS imaging products, plus a dedicated team of Olympus Clinical Application Specialists for ultrasound support, these new needles provide Olympus' customers with an unprecedented offering in the EUS suite."
For more information about Olympus EUS product and the EZ Shot 2 needles visit www.olympusamerica.com/eus or http://www.olympusamerica.com/msg_section/msg_eus_fineneedle.asp.
About Olympus Medical Systems Group
Olympus develops solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.
For more information visit Olympus at www.olympusamerica.com.
Media Contact: Megan Longenderfer Olympus America Inc., 484.896.5579, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE Olympus America Inc.|
Copyright©2010 PR Newswire.
All rights reserved